Europe pioneered biosimilars with early regulation and high adoption; the U.S. lagged due to legal and systemic barriers but is now accelerating fast. Learn how the two markets differ-and why biosimilars are reshaping global healthcare.
Olivia AHOUANGAN | Nov, 20 2025 Read More